Blog
Join in Upcoming Life Sciences Lunch Series, February 16th with Diana Caldwell as panelist
The Indiana Health Industry Forum (IHIF) and Barnes & Thornburg present “Clinical Trials from a Study Site Perspective” featuring Pearl Pathways’ own President and CEO, Diana Caldwell as a panelist. This presentation and luncheon will be held on February 16th at...
Webinar on What’s new with China FDA in 2016 from Pearl Pathways partner, Brandwood Biomedical – February 16th
On Tuesday, February 16th, learn the latest information on Decree 650 and changes in device guidance, regulations, and in-China clinical trials in a webinar presented by Brandwood Biomedical Director of China Operations, Steven Wen. Click here for your free...
Cancer Moonshot 2020
Sy Mukherjee, BioPharmaDive posted an article on PharmaVoice about Cancer Moonshot 2020 – a national effort to find the cure for cancer headed up by Vice President Joe Biden. Mukherjee explains that the National Immunotherapy Coalition (NIC) made up of large pharma,...
Follow us on Twitter @PearlPathways
Follow us on Twitter! Pearl IRB is part of a family of companies under the umbrella of Pearl Pathways. We have just launched the @PearlPathways twitter account which will include relevant IRB and clinical research updates about the industry and Pearl IRB. To keep up...
Remote Based Monitoring – new technology for clinical study data
Remote Based Monitoring (RBM) is technology that allows for remote access to data which has application for use in clinical studies. Melissa Fassbender, Outsourcing Pharma.com, recently published an article about RBM. Fassbender gave details where Propeller Health is...